共 44 条
- [31] Mathematical modeling for breast cancer risk assessment - State of the art and role in medicine - The Rubinstein et al article reviewed ONCOLOGY-NEW YORK, 2002, 16 (08): : 1098 - 1099
- [32] Pancreatic cancer: Incremental success in overcoming a major therapeutic challenge - The Senderowicz et al article reviewed: Advocate's perspective ONCOLOGY-NEW YORK, 2007, 21 (14): : 1712 - +
- [33] Nuclear Medicine Imaging in Breast Cancer: Current Strategies and Future Directions The Almubarak/Osman/Marano et al Article Reviewed ONCOLOGY-NEW YORK, 2009, 23 (03): : 269 - 270
- [34] Benefits and Pitfalls of Prostate Cancer Screening: "No Proof of Benefit" Does Not Equal "Proof of No Benefit" THE CROSWELL ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (06): : 466 - 468
- [35] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer - The Brave/Dagher/Farrell et al article reviewed ONCOLOGY-NEW YORK, 2006, 20 (11): : 1410 - 1411
- [36] Reconsidering the case for brachytherapy plus EBRT in high-risk prostate cancer - The Bittner/Merrick/Wallner et al article reviewed ONCOLOGY-NEW YORK, 2008, 22 (09): : 1006 - +
- [37] Perspectives on salvage therapy for non-small-cell lung cancer - The Cappuzzo/Finocchiaro/Trisolini et al article reviewed. ONCOLOGY-NEW YORK, 2005, 19 (08): : 995 - +
- [38] Costs of treating elderly patients with cancer: What are we measuring in the absence of reliable evidence? The McKoy/Fitzner/Edwards et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 858 - +
- [39] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer - The Brave et al article reviewed: Advocate's perspective ONCOLOGY-NEW YORK, 2006, 20 (11): : 1416 - 1416
- [40] 'Futile care': What to do when your patient insists on chemotherapy that likely won't help - The Khatcheressian/Harrington/Lcykholm et al article reviewed ONCOLOGY-NEW YORK, 2008, 22 (08): : 893 - +